Hims & Hers Health Q2 2023 Earnings Report $49.10 -17.32 (-26.07%) As of 02/21/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Earnings HistoryForecast Hims & Hers Health EPS ResultsActual EPS-$0.03Consensus EPS -$0.06Beat/MissBeat by +$0.03One Year Ago EPS-$0.10Hims & Hers Health Revenue ResultsActual Revenue$207.91 millionExpected Revenue$204.95 millionBeat/MissBeat by +$2.96 millionYoY Revenue Growth+83.10%Hims & Hers Health Announcement DetailsQuarterQ2 2023Date8/7/2023TimeAfter Market ClosesHIMS Upcoming EarningsHims & Hers Health will be holding an earnings conference call on Monday, February 24 at 5:00 PM Eastern. Interested parties can register for or listen to the call. Conference Call ResourcesConference CallConference Call TranscriptSlide DeckPress ReleaseHIMS Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Slide DeckFull Screen Slide DeckPowered by Hims & Hers Health Earnings HeadlinesHims & Hers Earnings Could Be a Game Changer—What to Do NowAfter a massive 500% run over the past 12 months, shares of Hims & Hers stock might have another trick saved up before earnings announcements.February 18, 2025 | marketbeat.comHims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short SupplyFebruary 22 at 8:39 AM | msn.comWatch This Robotics Demo Before March 17thJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."February 22, 2025 | Brownstone Research (Ad)Hims & Hers Acquires US-based Peptide FacilityFebruary 22 at 1:56 AM | businesswire.comWhy Hims & Hers Health Stock Is Plummeting TodayFebruary 21 at 2:37 PM | fool.comHims & Hers Stock Plummets. The Wegovy Shortage Is Over.February 21 at 1:19 PM | barrons.comSee More Hims & Hers Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Hims & Hers Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hims & Hers Health and other key companies, straight to your email. Email Address About Hims & Hers HealthHims & Hers Health (NYSE:HIMS) operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.View Hims & Hers Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles The Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? Upcoming Earnings Workday (2/24/2025)Intuit (2/25/2025)American Tower (2/25/2025)Bank of Montreal (2/25/2025)Bank of Nova Scotia (2/25/2025)Public Storage (2/25/2025)NVIDIA (2/26/2025)Synopsys (2/26/2025)Salesforce (2/26/2025)Lowe's Companies (2/26/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
